US Stock MarketDetailed Quotes

MCRB Seres Therapeutics

Watchlist
  • 1.230
  • +0.005+0.41%
Close Jul 22 16:00 ET
  • 1.210
  • -0.020-1.63%
Post 19:38 ET
186.28MMarket Cap-2084P/E (TTM)

Seres Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Seres Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 8, 2024

Revenue(YoY)

0.00

+100.00%
EPS(YoY)

-0.27

+52.63%
Analyst Rating

Buy

Jul 22, 2024

Seres Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
May 8, 20242024/Q10.000 / 250.000K--
Mar 5, 20242023/Q464.000K / -180.830K--
--2023/Q3310.000K / 853.000K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
May 8, 20242024/Q10.000 / 250.000K--
Mar 5, 20242023/Q464.000K / -180.830K--
--2023/Q3310.000K / 853.000K--

Unlock Free Earnings Estimates

Seres Therapeutics Earnings Reports

  • Seres Therapeutics | 10-Q: Quarterly report

    May 8 10:03 ET

  • Seres Therapeutics | 10-K: Annual report

    Mar 5 10:02 ET

  • Seres Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 10:00 ET

  • Seres Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 8, 2023 10:01 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 22, 2024

    Buy

    • Buy

      66.67%

    • Hold

      33.33%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg